Securi-T

Vinpocetine at 20 mg joins sage, blueberry, ashwagandha, phosphatidylserine, and uridine in a much more focused cognitive formula. Compared with the original, the active design is more focused or better specified, though the broader active blend carries more user-specific cautions and costs more to use routinely.

A defined 10 mg vinpocetine amount offers clearer and more focused dosing than the original 5 mg addition within a crowded botanical blend. Compared with the original, the active design is more focused or better specified, though reishi and the original urinary-oriented botanicals are absent and vinpocetine may affect blood pressure or clotting.

A 700 mg reishi fruiting-body double extract gives the mushroom component clearer sourcing and preparation than the original 100 mg reishi entry. Compared with the original, the active design is more focused or better specified, though vinpocetine is absent and the extract ratio and active-compound standardization are not stated.

A clear 10 mg vinpocetine amount doubles the original formula's small vinpocetine portion and removes its many lightly dosed botanicals. Routine cost is lower than the original, though it drops reishi and urinary-oriented ingredients and vinpocetine still warrants care with blood-pressure or clotting medicines.

Reishi fruit extract at 1,000 mg provides far more focused mushroom material than the original 100 mg reishi amount. Routine cost is lower than the original, though vinpocetine is absent and extraction ratio and active-compound standardization are not given.

Reishi powder and extract are paired with shiitake extract, creating a more substantial mushroom-focused option than the original. Routine cost is lower than the original, though vinpocetine is absent and mushroom-part, extraction-ratio, and standardization details are incomplete.

Ginkgo extract, 15 mg of vinpocetine, and Huperzia serrata create a compact circulation and cognitive-support blend. Useful active amounts and favorable routine cost improve the value trade-off, though ginkgo standardization and huperzine yield remain unclear and the formula does not retain reishi.

A 1,500 mg reishi amount provides much deeper mushroom coverage than the original formula at a low routine cost. Useful active amounts and favorable routine cost improve the value trade-off, though the label does not identify mushroom part, extraction method, or active-compound potency, and vinpocetine is absent.

A focused 10 mg vinpocetine amount is easier to assess and twice the original dose. Useful active amounts and favorable routine cost improve the value trade-off, though reishi and the urinary-oriented botanicals are absent and vinpocetine may lower blood pressure or affect clotting.